LJAC
FUSN

L.J. Altfest & Co’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

L.J. Altfest & Co’s Portfolio FUSN Stock Details FUSN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-10,213
Closed -$83K – 286
2021
Q2 		$83K Buy
10,213
+74
+0.7% +$637 0.02% 264
2021
Q1 		$109K Buy
+10,139
New +$119K 0.03% 270

Other funds holding FUSN

JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
ASP
Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

L.J. Altfest & Co's FUSN Position: Q3 2021 in Review

L.J. Altfest & Co sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q3 2021, closing a stake of 10,213 shares — an estimated $83K sold.

L.J. Altfest & Co first reported a position in FUSN in Q1 2021 and held it in 2 quarters. The position peaked at $109K in Q1 2021. 40 funds tracked by Wall St. Rank hold FUSN as of Q3 2021.

  • L.J. Altfest & Co reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q3 2021 after selling out during the quarter.
  • L.J. Altfest & Co sold 10,213 Fusion Pharmaceuticals Inc. Common Shares shares in Q3 2021, an estimated $83K.
  • L.J. Altfest & Co first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q1 2021 and held it in 2 quarters.
  • L.J. Altfest & Co's Fusion Pharmaceuticals Inc. Common Shares position peaked at $109K in Q1 2021.
  • 40 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q3 2021.

Based on L.J. Altfest & Co's 13F filing for Q3 2021, filed 12 Oct 2021.